Lisata Therapeutics, Inc. (LSTA)
1.935
+0.08
(+4.03%)
USD |
NASDAQ |
Sep 09, 12:39
Lisata Therapeutics Market Cap : 17.65M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 16.96M |
| September 04, 2026 | 15.05M |
| September 03, 2026 | 14.96M |
| September 02, 2026 | 14.32M |
| September 01, 2026 | 14.32M |
| August 31, 2026 | 13.59M |
| August 28, 2026 | 15.41M |
| August 27, 2026 | 16.60M |
| August 26, 2026 | 16.51M |
| August 25, 2026 | 15.87M |
| August 24, 2026 | 16.05M |
| August 21, 2026 | 14.13M |
| August 20, 2026 | 10.21M |
| August 19, 2026 | 10.21M |
| August 18, 2026 | 10.49M |
| August 17, 2026 | 9.848M |
| August 14, 2026 | 9.940M |
| August 13, 2026 | 10.30M |
| August 12, 2026 | 10.76M |
| August 11, 2026 | 11.03M |
| August 10, 2026 | 9.940M |
| August 07, 2026 | 9.666M |
| August 06, 2026 | 9.757M |
| August 05, 2026 | 10.21M |
| August 04, 2026 | 10.40M |
| Date | Value |
|---|---|
| August 03, 2026 | 9.472M |
| July 31, 2026 | 9.016M |
| July 30, 2026 | 9.380M |
| July 29, 2026 | 9.927M |
| July 28, 2026 | 10.56M |
| July 27, 2026 | 13.11M |
| July 24, 2026 | 15.21M |
| July 23, 2026 | 19.31M |
| July 22, 2026 | 20.04M |
| July 21, 2026 | 20.40M |
| July 20, 2026 | 32.10M |
| July 17, 2026 | 32.74M |
| July 16, 2026 | 31.88M |
| July 15, 2026 | 34.15M |
| July 14, 2026 | 33.79M |
| July 13, 2026 | 33.70M |
| July 10, 2026 | 29.78M |
| July 09, 2026 | 29.46M |
| July 08, 2026 | 29.23M |
| July 07, 2026 | 29.78M |
| July 06, 2026 | 30.51M |
| July 02, 2026 | 30.33M |
| July 01, 2026 | 30.60M |
| June 30, 2026 | 30.96M |
| June 29, 2026 | 30.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.773B |
| Alnylam Pharmaceuticals, Inc. | 34.20B |
| Anika Therapeutics, Inc. | 280.51M |
| Savara, Inc. | 1.105B |
| Vericel Corp. | 1.986B |
Market Cap Related Metrics
| PS Ratio | 172.62 |
| Price to Book Value | 2.140 |
| Price | 1.935 |
| Earnings Yield | -84.80% |